Twin Tree Management
CRL icon

Twin Tree Management’s Charles River Laboratories CRL Stock Holding History

Twin Tree Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,300
Closed -$3.99M – 1527
2025
Q2 		$3.99M Buy
+26,300
New +$3.51M 0.01% 1083
2024
Q3 		– Sell
-24,400
Closed -$5.04M – 1555
2024
Q2 		$5.04M Sell
24,400
-16,400
-40% -$3.72M 0.01% 761
2024
Q1 		$11.1M Sell
40,800
-4,900
-11% -$1.17M 0.02% 608
2023
Q4 		$10.8M Buy
45,700
+40,800
+833% +$8.02M 0.02% 668
2023
Q3 		$960K Sell
4,900
-1,100
-18% -$226K ﹤0.01% 978
2023
Q2 		$1.26M Hold
6,000
– – ﹤0.01% 977
2023
Q1 		$1.21M Buy
+6,000
New +$1.36M ﹤0.01% 979
2022
Q4 		– Sell
-3,300
Closed -$649K – 1330
2022
Q3 		$649K Buy
+3,300
New +$712K ﹤0.01% 1099

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Twin Tree Management's CRL Position: Q4 2025 in Review

Twin Tree Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 1,485 shares — an estimated $232K sold.

Twin Tree Management first reported a position in CRL in Q2 2018 and held it in 16 quarters. The position peaked at $7.44M in Q1 2022. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Twin Tree Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Twin Tree Management sold 1,485 Charles River Laboratories shares in Q4 2025, an estimated $232K.
  • Twin Tree Management first reported a position in Charles River Laboratories in Q2 2018 and held it in 16 quarters.
  • Twin Tree Management's Charles River Laboratories position peaked at $7.44M in Q1 2022.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.